PROK vs. FLYA, PFTA, LGST, AKLI, GETR, TWST, DNLI, NVAX, SWTX, and ACLX
Should you be buying ProKidney stock or one of its competitors? The main competitors of ProKidney include SOAR Technology Acquisition (FLYA), Perception Capital Corp. III (PFTA), Semper Paratus Acquisition (LGST), Akili (AKLI), Getaround (GETR), Twist Bioscience (TWST), Denali Therapeutics (DNLI), Novavax (NVAX), SpringWorks Therapeutics (SWTX), and Arcellx (ACLX).
ProKidney (NASDAQ:PROK) and SOAR Technology Acquisition (NYSE:FLYA) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, earnings, institutional ownership, analyst recommendations, valuation, profitability, community ranking, risk and media sentiment.
ProKidney currently has a consensus price target of $7.67, indicating a potential upside of 140.33%. Given ProKidney's higher probable upside, analysts plainly believe ProKidney is more favorable than SOAR Technology Acquisition.
51.6% of ProKidney shares are held by institutional investors. Comparatively, 62.2% of SOAR Technology Acquisition shares are held by institutional investors. 41.5% of ProKidney shares are held by insiders. Comparatively, 25.0% of SOAR Technology Acquisition shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
ProKidney received 6 more outperform votes than SOAR Technology Acquisition when rated by MarketBeat users.
In the previous week, ProKidney had 4 more articles in the media than SOAR Technology Acquisition. MarketBeat recorded 4 mentions for ProKidney and 0 mentions for SOAR Technology Acquisition. ProKidney's average media sentiment score of 0.00 equaled SOAR Technology Acquisition'saverage media sentiment score.
Summary
ProKidney beats SOAR Technology Acquisition on 5 of the 8 factors compared between the two stocks.
Get ProKidney News Delivered to You Automatically
Sign up to receive the latest news and ratings for PROK and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding PROK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
ProKidney Competitors List
Related Companies and Tools
